Passage Bio, Inc. (PASG) Tops Q4 EPS by 2c

Passage Bio, Inc. (NASDAQ: PASG) reported Q4 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs